Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Virology|July 11, 1998
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionN Kienzle, T B Sculley, L Poulsen, et al.
Journal of Virology|July 1, 1996
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequencesJ M Burrows, R Khanna, T B Sculley, et al.
Intervirology|January 1, 1988
Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virusT B Sculley, D G Sculley, J H Pope, et al.
International Journal of Cancer|September 15, 1990
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cellsI S Misko, C Schmidt, N Martin, et al.
Archives of Virology|January 28, 2004
Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteinsA Blood, C J Edwards, H H Ishii, et al.
Virology|August 1, 1989
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virusT B Sculley, A Apolloni, R Stumm, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipientsM T Kyaw, L Hurren, L Evans, et al.
Leukemia & Lymphoma|May 1, 1993
The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphomaM J Boyle, T B Sculley, R Penny, et al.
Clinical and Experimental Immunology|January 1, 1992
Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigenI S Misko, C Schmidt, M Honeyman, et al.
The Journal of Experimental Medicine|July 1, 1992
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentR Khanna, S R Burrows, M G Kurilla, et al.
Pageof 6